1-Methyl-2-[1,2,3]triazol-2-yl-1H-imidazo[4,5-c]pyridin-4-ylamine

ID: ALA198200

PubChem CID: 11494318

Max Phase: Preclinical

Molecular Formula: C9H9N7

Molecular Weight: 215.22

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Cn1c(-n2nccn2)nc2c(N)nccc21

Standard InChI:  InChI=1S/C9H9N7/c1-15-6-2-3-11-8(10)7(6)14-9(15)16-12-4-5-13-16/h2-5H,1H3,(H2,10,11)

Standard InChI Key:  ZKJVBCHQRNYBLS-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 16 18  0  0  0  0  0  0  0  0999 V2000
   -0.3500    0.1500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8458    0.8208    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6333    0.5625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8458   -0.5250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4750    0.1500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6333   -0.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9542   -0.5167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9542    0.8208    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3458    0.9750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0583    0.5625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7417    0.5625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7417   -0.2625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3458   -0.6792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3500    1.8000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5833   -1.3042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0583   -0.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  1  1  0
  5  1  1  0
  6  4  1  0
  7  5  1  0
  8  5  1  0
  9  3  2  0
 10  9  1  0
 11  8  2  0
 12  7  2  0
 13  6  2  0
 14  9  1  0
 15  4  1  0
 16 13  1  0
  3  6  1  0
 12 11  1  0
 10 16  2  0
M  END

Alternative Forms

1. Parent:

   

   ALA198200

   1-Methyl-2-[1,2,3]triazol-2-yl-1H-imidazo[4,5-c]pyridin-4-ylamine

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 215.22

Molecular Weight (Monoisotopic): 215.0919

AlogP: 0.13

#Rotatable Bonds: 1

Polar Surface Area: 87.44

Molecular Species: NEUTRAL

HBA: 7

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 6.62

CX LogP: 0.16

CX LogD: 0.10

Aromatic Rings: 3

Heavy Atoms: 16

QED Weighted: 0.62

Np Likeness Score: -1.00

References

1. Minetti P, Tinti MO, Carminati P, Castorina M, Di Cesare MA, Di Serio S, Gallo G, Ghirardi O, Giorgi F, Giorgi L, Piersanti G, Bartoccini F, Tarzia G..  (2005)  2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.,  48  (22): [PMID:16250647] [10.1021/jm058018d]

Source

Source(1):

• Scientific Literature